Cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in Canada

被引：0
|
作者：
Haiderali, AM
Villa, K
Schrammel, P
机构：
[1] Glaxo Wellcome, Mississauga, ON, Canada
[2] Lewin TEG Inc, Boston, MA USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
746
引用
收藏
页码：347A / 347A
页数：1
相关论文
共 50 条
  • [21] The cost-effectiveness of entecavir in the longterm treatment of nucleoside-naive and lamivudine-refractory chronic hepatitis B patients in Sweden
    Cerri, K. H.
    Yuan, Y.
    Zammit, D. C.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A300 - A301
  • [22] Cost-effectiveness of one-year treatment with lamivudine (Zeffix) or a single course of A-interferon in chronic hepatitis B.
    Lau, GK
    Cheung, R
    Payne, S
    Lai, C
    Lam, S
    [J]. HEPATOLOGY, 2000, 32 (04) : 589A - 589A
  • [23] Cost-effectiveness of oral treatments for chronic hepatitis B
    Dusheiko, Geoffrey M.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 623 - 625
  • [24] Cost comparison of interferon and lamivudine for the treatment of chronic hepatitis B
    Zacks, SL
    Fried, MW
    [J]. HEPATOLOGY, 1999, 30 (04) : 483A - 483A
  • [25] Treatment alternatives for chronic hepatitis B virus infection: A cost-effectiveness analysis
    Kanwal, F
    Gralnek, AM
    Martin, P
    Dulai, GS
    Farid, M
    Spiegel, BMR
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) : 821 - 831
  • [26] Chronic Hepatitis B Treatment: The Cost-Effectiveness of Interferon Compared to Lamivudin e
    Almeida, Alessandra Maciel
    da Silva, Anderson Lourenco
    Cherchiglia, Mariangela Leal
    Gurgel Andrade, Eli Iola
    Araujo de Oliveira, Gustavo Laine
    Acurcio, Francisco de Assis
    [J]. VALUE IN HEALTH, 2011, 14 (05) : S24 - S28
  • [27] COST-EFFECTIVENESS OF TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF CHRONIC HEPATITIS B IN TAIWAN
    Tan, E. C. H.
    Yehoshua, A.
    Jeyakumar, S.
    Peng, P.
    Lin, A. Y.
    Smith, N.
    Kachru, N.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S145 - S145
  • [28] Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis
    Nayeri, Unzila A.
    Werner, Erika F.
    Han, Christina S.
    Pettker, Christian M.
    Funai, Edmund F.
    Thung, Stephen F.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (03)
  • [29] Cost-effectiveness of chronic hepatitis C screening and treatment
    Lee, Hye Won
    Lee, Hankil
    Kim, Beom Kyung
    Chang, Young
    Jang, Jae Young
    Kim, Do Young
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (02) : 164 - 173
  • [30] Cost-effectiveness of treatment for chronic hepatitis C infection
    Bernstein, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 1993 - 1993
12345